Augmedix, Inc. (AUGX) Misses Q2 EPS by 3c

Augmedix, Inc. (NASDAQ: AUGX) reported Q2 EPS of ($0.16), $0.03 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $13.66 million versus the consensus estimate of $13.64 million.

For earnings history and earnings-related data on Augmedix, Inc. (AUGX) click here.

You May Also Be Interested In

• Bessent on Iran: maximum economic pressure means likely not a kinetic restart
• Jefferies Downgrades Sunway Healthcare Holdings (SUNMED:MK) to Hold
• Wolfe remains "broadly bullish on AI semis stocks", names Top Pick